U.S. flag An official website of the United States government
  1. Home
  2. Inspections, Compliance, Enforcement, and Criminal Investigations
  3. Criminal Investigations
  4. Press Releases
  5. Former Certified Nurse Practitioner Sentenced to 2 Years in Prison for Drug Diversion and Health Care Fraud
  1. Press Releases

Former Certified Nurse Practitioner Sentenced to 2 Years in Prison for Drug Diversion and Health Care Fraud

OCI Badge

Department of Justice
U.S. Attorney’s Office
Western District of Pennsylvania

Thursday, January 19, 2023

PITTSBURGH, PA. - A resident of Pittsburgh, Pennsylvania was sentenced in federal court on charges of drug diversion and health care fraud, United States Attorney Cindy K. Chung announced today.

Larry J. Goisse, Jr., 38, of the City’s Mt. Washington neighborhood, was sentenced to 24 months in prison to be followed by three years of supervised release by Senior United States District Judge Nora Barry Fischer. On October 4, 2022, Goisse pled guilty to one count of an Indictment charging him with drug diversion, and five counts of an Information charging him with health care fraud.

In connection with the guilty plea, the court was advised that in September 2018 through January 2019, Goisse, a former certified nurse practitioner, illegally prescribed the scheduled drug Aderall after his state medical license was revoked and he lost his DEA registration. In order to continue to receive payments from Medicare, Goisse submitted claims to Medicare for office visits under a co-worker’s license after suspension.

Judge Fischer stated that Aderall, the drug diverted by Goisse, is a highly addictive drug and could cause harm if incorrectly prescribed. Goisse’s conduct in diverting Aderall created a serious harm beyond monetary loss and that Goisse’s actions had a destructive effect on his patients relying on him for health care.

Assistant United States Attorney Robert S. Cessar is prosecuting this case on behalf of the government.

The investigation leading to the filing of charges in this case was conducted by the Western Pennsylvania Opioid Fraud and Abuse Detection Unit (OFADU). The Western Pennsylvania OFADU, led by federal prosecutors in the U.S. Attorney’s Office, combines the expertise and resources of federal and state law enforcement to address the role played by unethical medical professionals in the opioid epidemic.

The agencies which comprise the Western Pennsylvania OFADU include: Federal Bureau of Investigation, U.S. Health and Human Services – Office of Inspector General, Drug Enforcement Administration, Internal Revenue Service-Criminal Investigations, Pennsylvania Office of Attorney General - Medicaid Fraud Control Unit, Pennsylvania Office of Attorney General – Bureau of Narcotic Investigations, United States Postal Inspection Service, U.S. Attorney’s Office – Criminal Division, Civil Division and Asset Forfeiture Unit, Department of Veterans Affairs-Office of Inspector General, Food and Drug Administration-Office of Criminal Investigations, U.S. Office of Personnel Management – Office of Inspector General and the Pennsylvania Bureau of Licensing.

Prescription Drugs
Health Care Fraud

USAO - Pennsylvania, Western

Back to Top